Company Farmacarmen Srl with Fiscal Code 1122464
recorded a turnover of 2024 of
22.410,
with a net profit of
-10.402
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Farmacarmen Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
48.164
44.355
56.598
90.269
41.281
35.662
37.898
33.505
34.377
22.410
Total Income - EUR
48.949
44.776
56.599
91.065
41.761
35.662
45.984
33.505
45.213
22.410
Total Expenses - EUR
56.417
51.316
69.608
99.985
48.045
39.863
48.419
38.890
44.592
32.813
Gross Profit/Loss - EUR
-7.468
-6.540
-13.009
-8.920
-6.284
-4.201
-2.436
-5.385
621
-10.402
Net Profit/Loss - EUR
-8.936
-6.988
-13.575
-9.831
-6.701
-4.429
-2.814
-5.722
169
-10.402
Employees
3
2
2
2
2
1
2
2
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -34.4%, from 34.377 euro in the year 2023, to 22.410 euro in 2024.
The Net Profit decreased by -168 euro, from 169 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Farmacarmen Srl
Financial Rating - FARMACARMEN SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Farmacarmen Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Farmacarmen Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Farmacarmen Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
4.712 euro in 2024 which includes Inventories of
0 euro, Receivables of
4.621 euro and cash availability of
91 euro.
The company's Equity was valued at
-54.949 euro, while total Liabilities amounted to
59.661 euro.
Equity decreased by -10.402 euro, from -44.797 euro in 2023, to -54.949 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Farmacarmen Srl